CYTEK BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CYTEK BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 87.53K shares, a 33.30% decline year-over-year.
- CYTEK BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 67.20K shares, a 50.57% increase year-over-year.
- CYTEK BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 97.56K shares, a 62.59% decline year-over-year.
- CYTEK BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 280.45K shares, a 262.58% increase year-over-year.
- CYTEK BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 553.86K shares, a 32.56% decline from fiscal 2024.
- CYTEK BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 821.27K shares, a 25.28% decline from fiscal 2023.
- CYTEK BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 1.10M shares, a 10.24% decline from fiscal 2022.
- CYTEK BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 1.22M shares, a 5.05% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 87.53K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | 532.73K shares derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 67.20K shares 10-Q · filed 2026-05-07 | 576.43K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 97.56K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 553.86K shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 280.45K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | 717.06K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-06-30 | 131.23K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | 513.96K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-03-31 | 44.63K shares 10-Q · filed 2025-05-08 | 593.23K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-12-31 | 260.76K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 821.27K shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 77.35K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 748.26K shares derived: sum of 4 quarters · filed 2025-02-28 |
| 2024-06-30 | 210.49K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | 861.09K shares derived: sum of 4 quarters · filed 2025-02-28 |
| 2024-03-31 | 272.67K shares 10-Q · filed 2024-05-08 | 1.17M shares derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-12-31 | 187.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | 1.10M shares 10-K · filed 2025-02-28 |
| 2023-09-30 | 190.18K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 1.25M shares derived: sum of 4 quarters · filed 2024-03-13 |
| 2023-06-30 | 519.01K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 1.26M shares derived: sum of 4 quarters · filed 2024-03-13 |
| 2023-03-31 | 202.22K shares 10-Q · filed 2023-05-09 | 933.51K shares derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-12-31 | 341.27K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | 1.22M shares 10-K · filed 2024-03-13 |
| 2022-09-30 | 194.01K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 907.22K shares derived: sum of 4 quarters · filed 2023-03-01 |
| 2022-06-30 | 196.02K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | 1.12M shares derived: sum of 4 quarters · filed 2023-03-01 |
| 2022-03-31 | 493.27K shares 10-Q · filed 2022-05-12 | |
| 2021-12-31 | 23.92K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 1.29M shares 10-K · filed 2023-03-01 |
| 2021-09-30 | 411.06K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | |
| 2020-12-31 | 756.42K shares 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |